This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignees: Massachusetts Eye and Ear Infirmary, The Schepens Eye Research Institute, Inc.. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2022-2025
Title: Innovations by Yin Shan Eric Ng
Introduction
Yin Shan Eric Ng is an accomplished inventor based in North Billerica, MA (US). He has made significant contributions to the field of retinal research, particularly in the development of therapies aimed at neuroprotection and regeneration of retinal cells. With a total of 2 patents, his work has the potential to impact the treatment of age-related macular degeneration and other retinal disorders.
Latest Patents
Ng's latest patents include "Engineered VEGF variants for retinal neuroprotection, promotion of axon growth and axon regeneration." This invention provides methods for promoting retinal ganglion axon formation, survival, and synapse formation. Another notable patent is "Compounds and compositions for inhibiting retinal pigment epithelium degeneration and methods using the same." This patent presents compounds capable of inhibiting retinal pigment epithelium degeneration or geographic atrophy associated with age-related macular degeneration, along with methods for their application.
Career Highlights
Throughout his career, Ng has worked with prestigious institutions such as The Schepens Eye Research Institute, Inc. and Massachusetts Eye and Ear Infirmary. His research has focused on innovative solutions to complex retinal issues, showcasing his dedication to advancing medical science.
Collaborations
Ng has collaborated with notable colleagues, including Gopalan Gnanaguru and Ashley Mackey, who have contributed to his research endeavors.
Conclusion
Yin Shan Eric Ng's innovative work in retinal research and his patented inventions highlight his commitment to improving vision health. His contributions are paving the way for new treatments in the field of ophthalmology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile